Protagonist Therapeutics Inc. PTGX
$110.09
▼ -0.01% 24H
About
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company targets unmet medical needs in areas such as hematology, blood disorders, inflammation, immunology, and metabolic…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees128
TickerPTGX
Statistics
Market Cap$7.07B
Revenue (TTM)$46.0M
Net Income-$130.1M
Net Margin-282.8%
EPS$-2.05
P/E139.52
P/S93.47
P/B10.55
EV/EBITDA-44.47
ROE-17.1%
Dividend Yield—
Price$110.09
Data: Twelve Data · Revenue = mcap / P/S